Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD45RA-depleted DLI after TCR-alpha/beta depleted HSCT
NCT02337595Phase 2Completed
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- Aug 2014
- Primary completion
- Mar 2015
- Modality
- Prophylactic Vaccines, Cell Therapies, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of CD45RA-depleted peripheral blood mononuclear cells in opportunistic infection, graft-versus-host disease (GVHD), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Started Aug 2014; status: completed.
02
Drugs
CD45RA-depleted peripheral blood mononuclear cells
03
Conditions
opportunistic infectiongraft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02337595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02337595.